Biotech M&A Anomalies With Allan Shaw
Business Of Biotech
00:00
Introduction
Matt Piller: Biotech investors are still getting banged up out there, but some analysts are pointing to recovery on the back half of this year and into Q1 2023. Alan Shaw recently played a hand in some all too rare of late M&A activity, helping portage biotech acquire terrace pharmaceuticals. We're going to talk about some market forecasts and here with me in the studio is Alan.
Transcript
Play full episode
